Morgan Stanley significantly reduced its price target for Oracle (ORCL), slashing it from $320 down to $213, citing high investment costs associated with the company's "GPU-as-a-Service" expansion.
- The firm maintained its Equal Weight rating on the stock.
- The downgrade added pressure to ORCL shares, which are already grappling with existing leverage and litigation concerns.
- Shares reacted negatively to the news, trading down 2.70% during the session.